Screener
Lineage Cell Therapeutics LCTX Q1 2025 earnings
Reported May 13, 2025 · After market close
Revenue$1.5MMiss by $222.3K
EPS-$0.02In line
Revenue estimate$1.7M
EPS estimate-$0.02
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.3M
EPS estimate-$0.03
Versus estimates
Revenue
FAQ
- When did Lineage Cell Therapeutics report Q1 2025 earnings?
- Lineage Cell Therapeutics (LCTX) reported Q1 2025 earnings on May 13, 2025 after market close.
- What were Lineage Cell Therapeutics's Q1 2025 revenue and EPS?
- Lineage Cell Therapeutics reported revenue of $1.5M and eps of $-0.02 for Q1 2025.
- Did Lineage Cell Therapeutics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.7M by $222.3K. EPS beat the consensus estimate of $-0.02 by $0.00.
- How did Lineage Cell Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 4.0% from $1.4M a year earlier and eps grew 50.0% from $-0.04.
- Where can I find Lineage Cell Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-070337) and the 10-Q periodic report (0000950170-25-070378) directly on SEC EDGAR. The filing index links above go to sec.gov.
